Mitochondrial dysfunction and oxidative stress in autism spectrum disorder: pharmacological insights into natural antioxidants
Frontiers in Pharmacology · 15.04.2026 · 17
DOI: 10.3389/fphar.2026.1783888 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.04.2026. Verfasst von Marta Sofia Scenna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuropharmacology and Applied pharmacology, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, It…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by social communication deficits, restricted and fixated interests and abnormal motor behaviors. Increasing evidence implicates oxidative stress, mitochondrial dysfunction, and neuroinflammation as key biological features of ASD. Aberrant redox homeostasis, reduced glutathione reserves, increased lipid peroxidation, and dysregulated NRF2 signaling have been documented in both peripheral tissues and brain samples. Post-mortem and imaging studies further reveal deficits in electron transport chain complexes and pyruvate dehydrogenase activity, suggesting a mechanistic link between mitochondrial bioenergetics and ASD-related phenotypes. These pathomechanisms have motivated interest in antioxidant metabolites from botanical drugs and nutrients as complementary strategies. To critically appraise mechanisms and levels of evidence ( in vitro, in vivo , clinical) for vitamin E and C, glutathione and its precursors, polyphenols (quercetin, resveratrol, curcumin), Crocus sativus carotenoids (crocin/safranal), and “indirect” modulators (e.g., omega-3, folinic acid), emphasizing study quality, translational relevance, and limitations. The aim of this review is to synthesize current findings on the potential benefits of antioxidants in addressing both molecular and behavioral aspects of ASD, while also examining the link between oxidative stress and ASD. Furthermore, we discuss the role of antioxidant-based interventions in managing ASD symptoms. The review highlights the complex challenges associated with antioxidant therapies and deficiencies, emphasizing the need for a multifaceted nutritional approach particularly in children with ASD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Neuropharmacology and Applied pharmacology, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
- Department of the Chemical-Toxicological and Pharmacological Evaluation of Drugs, Faculty of Pharmacy, Catholic University Our Lady of Good Counsel, Tirana, Albania.
Zitieren
APA
Scenna, M. S., Bej, E., Cesare, P., Persichitti, I., Cimini, A., D'Angelo, M., & Castelli, V. (2026). Mitochondrial dysfunction and oxidative stress in autism spectrum disorder: pharmacological insights into natural antioxidants. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1783888
Vancouver
Scenna MS, Bej E, Cesare P, Persichitti I, Cimini A, D'Angelo M, et al. Mitochondrial dysfunction and oxidative stress in autism spectrum disorder: pharmacological insights into natural antioxidants. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1783888
BibTeX
@article{Scenna2026,
author = {Scenna, Marta Sofia and Bej, Erjola and Cesare, Patrizia and Persichitti, Ilaria and Cimini, Annamaria and D'Angelo, Michele and Castelli, Vanessa},
title = {Mitochondrial dysfunction and oxidative stress in autism spectrum disorder: pharmacological insights into natural antioxidants},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1783888}
}
EUVIMED